ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,284Medicare Part D Prescriptions Filled, Including Refills

Rank: 141 out of 917

$458K Total Retail Price of All Prescriptions

Rank: 148 out of 917

442 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 442 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 442 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,696 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 375 359 1 2
LISINOPRIL 354 345 2 1
FUROSEMIDE 324 313 3 7
AMLODIPINE BESYLATE 300 285 4 5
HYDROCODONE-ACETAMINOPHEN 276 248 S3 5 6
LEVOTHYROXINE SODIUM 260 258 6 3
OMEPRAZOLE 239 216 7 4
METOPROLOL TARTRATE 196 177 8 11
HYDROCHLOROTHIAZIDE 191 183 9 9
LOSARTAN POTASSIUM 165 162 10 13
POTASSIUM CHLORIDE 142 139 11 16
METFORMIN HCL 139 131 12 8
METOPROLOL SUCCINATE 135 132 13 18
DONEPEZIL HCL 133 133 14 32
ATORVASTATIN CALCIUM 128 126 15 14
SERTRALINE HCL 124 104 16 24
ATENOLOL 122 110 17 12
RANITIDINE HCL 110 110 18 29
TRAZODONE HCL 107 100 19 22
GABAPENTIN 99 89 20 17
ZOLPIDEM TARTRATE 95 77 21 21
PRAVASTATIN SODIUM 94 81 22 20
FENTANYL 88 81 S2 23 58
WARFARIN SODIUM 85 85 24 10
TAMSULOSIN HCL 85 85 24 25
CLOPIDOGREL 76 71 26 50
ALLOPURINOL 66 64 27 31
FLUTICASONE PROPIONATE 65 61 28 26
CITALOPRAM HBR 64 64 29 15
NAMENDA 63 63 30 43
METHOCARBAMOL 61 34 R 31 87
OXYBUTYNIN CHLORIDE 60 60 32 76
GEMFIBROZIL 60 34 32 140
VESICARE 59 47 34 166
SPIRIVA 58 53 35 45
MORPHINE SULFATE ER 58 41 S2 35 48
PREDNISONE 57 57 37 34
AZITHROMYCIN 51 48 38 61
PANTOPRAZOLE SODIUM 51 51 38 44
LANTUS SOLOSTAR 50 40 40 63
ZETIA 50 50 40 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.